BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17845393)

  • 1. Effects of cytapheresis on tumor necrosis factor receptor and on expression of CD63 in myeloperoxidase--antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Hasegawa M; Nishii C; Kabutan N; Kato M; Ohashi A; Nakai S; Murakami K; Tomita M; Nabeshima K; Hiki Y; Oshima H; Sugiyama S
    Ther Apher Dial; 2007 Oct; 11(5):337-40. PubMed ID: 17845393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Hasegawa M; Nishii C; Ohashi A; Tomita M; Nakai S; Murakami K; Nabeshima K; Fujita Y; Ishii J; Hiki Y; Sugiyama S
    Nephron Clin Pract; 2009; 113(3):c222-33. PubMed ID: 19690440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients.
    Hasegawa M; Ohashi A; Kabutan N; Hiramatsu S; Kato M; Murakami K; Tomita M; Nabeshima K; Hiki Y; Sugiyama S
    Ther Apher Dial; 2006 Oct; 10(5):412-8. PubMed ID: 17096695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors.
    Hasegawa M; Watanabe A; Takahashi H; Takahashi K; Kasugai M; Kawamura N; Kushimoto H; Murakami K; Tomita M; Nabeshima K; Oohashi A; Kondou F; Ooshima H; Hiki Y; Sugiyama S
    Ther Apher Dial; 2005 Aug; 9(4):297-302. PubMed ID: 16076370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
    Denollet J; Vrints CJ; Conraads VM
    Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.
    Dodé C; Papo T; Fieschi C; Pêcheux C; Dion E; Picard F; Godeau P; Bienvenu J; Piette JC; Delpech M; Grateau G
    Arthritis Rheum; 2000 Jul; 43(7):1535-42. PubMed ID: 10902757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection.
    Wang L; Chen RF; Liu JW; Yu HR; Kuo HC; Yang KD
    Am J Trop Med Hyg; 2007 Aug; 77(2):297-302. PubMed ID: 17690402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
    Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
    Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between tumour necrosis factor receptor types 1 and 2 gene polymorphism and severe acute alcoholic hepatitis.
    Nguyen-Khac E; Houchi H; Daoust M; Dupas JL; Naassila M
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):794-800. PubMed ID: 19641466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
    Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
    Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of preoperative carbohydrate loading on the changes in serum tumor necrosis factor receptors 1 and 2 and insulin resistance in patients of colon carcinoma].
    An GQ; Zhao XL; Gao YC; Wang GY; Yu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2041-4. PubMed ID: 19080431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis.
    Ikezawa-Suzuki I; Shimada Y; Tai H; Komatsu Y; Tanaka A; Yoshie H
    J Clin Periodontol; 2008 Nov; 35(11):961-8. PubMed ID: 18823344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder.
    Grassi-Oliveira R; Brietzke E; Pezzi JC; Lopes RP; Teixeira AL; Bauer ME
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):202-8. PubMed ID: 19175760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.